Park Pyeongtak
Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
Latest Articles
SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks
Daewoong Pharmaceutical’s ‘Ursa’ Shows Symptom Improvement in Early Post-COVID Patients
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
LigaChemBio Receives Milestone from Czech Sotio Biotech
powered by 